About: The first case was that of a 58–year–old man diagnosed with coronavirus disease 2019 (COVID–19) pneumonia after 7 days of fever. Favipiravir was administered on admission; however, the patient’s respiratory status worsened with high fever. On day 2 of admission, after tracheal intubation, maintaining oxygenation was difficult after initiating mechanical ventilation, and extracorporeal membrane oxygenation (ECMO) was initiated. On day 5, prone positioning and corticosteroid therapy were started. The patient was weaned from ECMO on day 9 and from ventilator support on day 11. On day 27, he was discharged ambulatory. The second case was that of a 44–year–old man who complained of dyspnea after 12 days of fever. After tracheal intubation, he was diagnosed with COVID–19 pneumonia. Favipiravir was administered on admission; nevertheless, the patient’s respiratory status worsened gradually with high fever. On day 4 of admission, ECMO and corticosteroid therapy were initiated. On day 5, prone positioning was started. The patient was weaned from ECMO on day 12 and from ventilator support on day 15. On day 30, he was discharged ambulatory. The aggravation of COVID–19 pneumonia may be associated with excessive inflammation; therefore, some patients were effectively treated with corticosteroid therapy.   Goto Sponge  NotDistinct  Permalink

An Entity of Type : fabio:Abstract, within Data Space : wasabi.inria.fr associated with source document(s)

AttributesValues
type
value
  • The first case was that of a 58–year–old man diagnosed with coronavirus disease 2019 (COVID–19) pneumonia after 7 days of fever. Favipiravir was administered on admission; however, the patient’s respiratory status worsened with high fever. On day 2 of admission, after tracheal intubation, maintaining oxygenation was difficult after initiating mechanical ventilation, and extracorporeal membrane oxygenation (ECMO) was initiated. On day 5, prone positioning and corticosteroid therapy were started. The patient was weaned from ECMO on day 9 and from ventilator support on day 11. On day 27, he was discharged ambulatory. The second case was that of a 44–year–old man who complained of dyspnea after 12 days of fever. After tracheal intubation, he was diagnosed with COVID–19 pneumonia. Favipiravir was administered on admission; nevertheless, the patient’s respiratory status worsened gradually with high fever. On day 4 of admission, ECMO and corticosteroid therapy were initiated. On day 5, prone positioning was started. The patient was weaned from ECMO on day 12 and from ventilator support on day 15. On day 30, he was discharged ambulatory. The aggravation of COVID–19 pneumonia may be associated with excessive inflammation; therefore, some patients were effectively treated with corticosteroid therapy.
Subject
  • Intensive care medicine
  • Medical equipment
  • Membrane technology
part of
is abstract of
is hasSource of
Faceted Search & Find service v1.13.91 as of Mar 24 2020


Alternative Linked Data Documents: Sponger | ODE     Content Formats:       RDF       ODATA       Microdata      About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data]
OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software